- Trading turnover of CHF 1,050.0 billion (+13.4% versus the same period in 2013)
- Sixth IPO of 2014: Molecular Partners now listed on SIX Swiss Exchange
- Launch of Sponsored Foreign Shares trading segment
Since the start of 2014, a total of 35,519,076 transactions have been conducted on SIX Swiss Exchange and SIX Structured Products Exchange. This is 11.0% up on the same period last year. In the equities including funds + ETPs segment alone, 33,469,185 transactions have been registered, equating to a rise of 12.1%. 463,771 (-0.6%) transactions have been conducted in the CHF bonds segment.
Since the start of 2014, trading turnover across all securities has risen by 13.4% in total to CHF 1,050.0 billion. Trading turnover as at November had thus already exceeded the total for 2013. This increase is primarily attributable to turnover in the equities including funds + ETPs segment (+17.6%). Turnover in CHF bonds increased by 0.7% to CHF 153.9 billion. A slight fall of 0.2% to CHF 82.4 billion was recorded for ETFs, however, while for structured products and warrants the turnover dropped by 12.3% to CHF 24.7 billion.
November 2014 saw a total of 2,980,626 trades with a turnover of CHF 89.8 billion, meaning that the values of the prior month were not achieved. The number of transactions fell by 31.3% and turnover by 27.0%. This can be attributed to the fact that November included three fewer trading days than the prior month, which was also the strongest month since August 2011.
The performance of the equities including funds + ETPs segment was as follows: there were 2,807,078 trades, a decrease of 31.9% on the previous month, with turnover down by 30.5% to CHF 65.8 billion. Trading turnover in ETFs fell by 28.6% to CHF 6.5 billion, with the number of trades declining by 20.7% to 69,916. Turnover in structured products and warrants decreased by 27.7% to CHF 1.8 billion. In addition, there were 27.0% fewer transactions, at 63,796. CHF bond trades were down by 8.9% to 38,445, with turnover falling by 1.1% to CHF 15.1 billion.
33 new CHF bond issues (+3.1%) and 2,888 new structured products and warrants (-38.4%) were admitted to trading in November. In all, this means that 338 new CHF bonds (+11.2%) and 36,612 new structured products and warrants (-14.5%) have been listed since the start of the year. The listing of biotech company Molecular Partners was also the sixth IPO conducted on SIX Swiss Exchange this year. The Sponsored Foreign Shares trading segment, in which more than 500 blue chip equities from 27 different countries can be traded, was likewise launched in November. Renell Wertpapierhandelsbank AG and ICF BANK AG Wertpapierhandelsbank will act as the first sponsors and thus as market makers.
The performance of the most important equity indices was as follows in November 2014: The blue chip SMI® index stood at 9,150.5 points at the end of November (+3.5% month-on-month, +11.6% versus end-2013). The SLI Swiss Leader Index® stood at 1,351.9 points (+3.2%/+7.5%) and the broader-based SPI® at 8,992.9 points (+3.5%/+14.7%). The SBI® AAA-BBB Total Return index was up versus October (+0.9%/+5.9% compared with end-2013) at 131.0 points.